Mankind Pharma Mankind Pharma is a pharmaceutical company developing, commercializing, and delivering medicines. | ![]() Syngene International Syngene International is integrated research, development, and manufacturing company providing scientific services. | ![]() Biological E Biological E (also known as BE, formerly Biological Products Private) is a biological products and pharmaceuticals company that manufacturer and supplies vaccines. | ![]() Novo Nordisk Novo Nordisk is a healthcare company that designs and manufactures pharmaceutical products. | ![]() UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions. | |
Founding Date | Founding Date 1995 | Founding Date 1993 | Founding Date 1953 | Founding Date 1923 | Founding Date 1928 |
Type | Type Private | Type Public | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations New Delhi, IN HQ | Locations Bangalore, IN HQ Bangalore, IN Bengaluru, IN | Locations Hyderabad, IN HQ Hyderabad, IN Kolthur, IN Zug, CH Cary, US | Locations Bagsværd, DK HQ Tirana, AL Boufarik, DZ Hydra, DZ Tizi Ouzou, DZ Buenos Aires, AR North Sydney, AU see more | Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more |
Employees | Employees 16,2532% increase | Employees 6,510 | Employees 4,3162% increase | Employees 77,406 | Employees 9,052 |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 599.3 b | Valuation ($) 34.3 b |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) ₹37.4b (FY, 2026) | Revenue (est.) ₹9.3b (FY, 2019) | Revenue (est.) kr309.1b (FY, 2025) | Revenue (est.) €7.4b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods ₹9.2b (FY, 2026) | Cost of goods N/A | Cost of goods kr46.1b (FY, 2025) | Cost of goods €1.4b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit ₹28.9b (FY, 2026) | Gross profit N/A | Gross profit kr263b (FY, 2025) | Gross profit €7.2b (FY, 2025) |
Net income | Net income N/A | Net income ₹3.2b (FY, 2026) | Net income N/A | Net income kr102.4b (FY, 2025) | Net income €1.6b (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised $ 239m | Total funding raised $ 62m | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A |

Syngene International is integrated research, development, and manufacturing company providing scientific services.
View company
Biological E (also known as BE, formerly Biological Products Private) is a biological products and pharmaceuticals company that manufacturer and supplies vaccines.
View company
Novo Nordisk is a healthcare company that designs and manufactures pharmaceutical products.
View company
UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
View company